{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:03:42Z","timestamp":1788455022096,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["Unione europea-Next Generation EU\u2013 PNRR M6C2 - Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN, progetto PNRR-MR1-2022-12375914"],"award-info":[{"award-number":["Unione europea-Next Generation EU\u2013 PNRR M6C2 - Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN, progetto PNRR-MR1-2022-12375914"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Wolfram Syndrome (WFS) is a rare, multisystemic, degenerative disease leading to premature death. Clinical and genetic heterogeneity makes WFS diagnosis and management challenging. The Italian Society of Diabetes (SID) and the Italian Society for Pediatric Endocrinology and Diabetology (SIEDP) convened an expert panel of professional healthcare practitioners to provide up-to-date knowledge about the pathophysiology, clinical presentation and treatment of WFS, and recommendations for the earlydetection and optimal disease management. The consensus recommends the revision of diagnostic protocols to include genetic testing and comprehensive multidisciplinary evaluations to ensure accurate diagnosis of WFS, advocates for personalized management plans tailored to the unique needs of each patient, with an emphasis on exploring new potential drug therapies. A holistic care model that addresses the medical, psychological, and social challenges faced by patients with WFS and their families is strongly endorsed. The opinion underscores the importance of educating healthcare professionals about WFS to enhance early diagnosis and intervention, aiming to improve outcomes for patients through practical and evidence-based clinical strategies.<\/jats:p>","DOI":"10.1007\/s40618-024-02495-z","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T23:49:26Z","timestamp":1731282566000},"page":"507-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["SID\/SIEDP expert consensus on optimizing clinical strategies for early detection and management of wolfram syndrome"],"prefix":"10.1007","volume":"48","author":[{"given":"Giulio","family":"Frontino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Delvecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Prudente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Daniela","family":"Sordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Barboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Di Giamberardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Rutigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Caretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Cascavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"D\u2019Annunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-2198","authenticated-orcid":false,"given":"Lorenzo","family":"Piemonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"2495_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/BJO.60.4.294","volume":"60","author":"SFJ Pilley","year":"1976","unstructured":"Pilley SFJ, Thompson HS, Hart E, Foundations K (1976) Familial syndrome of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness (didmoad) in childhood. Br J Ophthalmol 60:294. https:\/\/doi.org\/10.1136\/BJO.60.4.294","journal-title":"Br J Ophthalmol"},{"key":"2495_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/J.1399-5448.2009.00518.X","volume":"11","author":"S Kumar","year":"2010","unstructured":"Kumar S (2010) Wolfram syndrome: important implications for pediatricians and pediatric endocrinologists. Pediatr Diabetes 11:28\u201337. https:\/\/doi.org\/10.1111\/J.1399-5448.2009.00518.X","journal-title":"Pediatr Diabetes"},{"key":"2495_CR3","first-page":"715","volume":"13","author":"DJ Wolfram","year":"1938","unstructured":"Wolfram DJ, Wagener HP (1938) Diabetes mellitus and simple optic atrophy among siblings: report of four cases. Mayo Clin Proc 13:715\u2013718","journal-title":"Mayo Clin Proc"},{"key":"2495_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.14.3.190","author":"FC Fraser","year":"1977","unstructured":"Fraser FC, Gunn T (1977) Diabetes mellitus, diabetes insipidus, and optic atrophy. An autosomal recessive syndrome? J Med Genet 14. https:\/\/doi.org\/10.1136\/jmg.14.3.190","journal-title":"J Med Genet"},{"key":"2495_CR5","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.12.1566","author":"BT Kinsley","year":"1995","unstructured":"Kinsley BT, Swift M, Dumont RH, Swift RG (1995) Morbidity and mortality in the Wolfram syndrome. Diabetes Care 18. https:\/\/doi.org\/10.2337\/diacare.18.12.1566","journal-title":"Diabetes Care"},{"key":"2495_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92473-6","author":"TG Barrett","year":"1995","unstructured":"Barrett TG, Bundey SE, Macleod AF (1995) Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(95)92473-6","journal-title":"Lancet"},{"key":"2495_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-019-0487-4","author":"L Rigoli","year":"2020","unstructured":"Rigoli L, Aloi C, Salina A et al (2020) Wolfram syndrome 1 in the Italian population: genotype\u2013phenotype correlations. Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-019-0487-4. 87:","journal-title":"Pediatr Res"},{"key":"2495_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-013-0039-4","author":"F Lombardo","year":"2014","unstructured":"Lombardo F, Salzano G, Di Bella C et al (2014) Phenotypical and genotypical expression of Wolfram syndrome in 12 patients from a sicilian district where this syndrome might not be so infrequent as generally expected. J Endocrinol Invest 37. https:\/\/doi.org\/10.1007\/s40618-013-0039-4","journal-title":"J Endocrinol Invest"},{"key":"2495_CR9","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/J.1464-5491.2011.03377.X","volume":"28","author":"MA Ganie","year":"2011","unstructured":"Ganie MA, Laway BA, Nisar S et al (2011) Presentation and clinical course of Wolfram (DIDMOAD) syndrome from North India. Diabet Med 28:1337\u20131342. https:\/\/doi.org\/10.1111\/J.1464-5491.2011.03377.X","journal-title":"Diabet Med"},{"key":"2495_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/J.JCLINEPI.2013.12.002","volume":"67","author":"IR Diamond","year":"2014","unstructured":"Diamond IR, Grant RC, Feldman BM et al (2014) Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol 67:401\u2013409. https:\/\/doi.org\/10.1016\/J.JCLINEPI.2013.12.002","journal-title":"J Clin Epidemiol"},{"key":"2495_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddg214","author":"S Hofmann","year":"2003","unstructured":"Hofmann S, Philbrook C, Gerbitz KD, Bauer MF (2003) Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Mol Genet 12. https:\/\/doi.org\/10.1093\/hmg\/ddg214","journal-title":"Hum Mol Genet"},{"key":"2495_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-15-88","author":"E Mozzillo","year":"2014","unstructured":"Mozzillo E, Delvecchio M, Carella M et al (2014) A novel CISD2 intragenic deletion, optic neuropathy and platelet aggregation defect in Wolfram syndrome type 2. BMC Med Genet 15. https:\/\/doi.org\/10.1186\/1471-2350-15-88","journal-title":"BMC Med Genet"},{"key":"2495_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s004310000704","author":"M Al-Sheyyab","year":"2001","unstructured":"Al-Sheyyab M, Jarrah N, Younis E et al (2001) Bleeding tendency in Wolfram syndrome: a newly identified feature with phenotype genotype correlation. Eur J Pediatr 160. https:\/\/doi.org\/10.1007\/s004310000704","journal-title":"Eur J Pediatr"},{"key":"2495_CR14","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1296","author":"E De Franco","year":"2017","unstructured":"De Franco E, Flanagan SE, Yagi T et al (2017) Dominant ER stress-inducing WFS1 mutations underlie a genetic syndrome of neonatal\/infancy-onset diabetes, congenital sensorineural deafness, and congenital cataracts. Diabetes 66. https:\/\/doi.org\/10.2337\/db16-1296","journal-title":"Diabetes"},{"key":"2495_CR15","doi-asserted-by":"crossref","unstructured":"de Muijnck C, Brink JB ten, Bergen AA et al (2023) Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum. Surv Ophthalmol 68","DOI":"10.1016\/j.survophthal.2023.01.012"},{"key":"2495_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/J.DIABRES.2005.12.007","volume":"73","author":"A Nakamura","year":"2006","unstructured":"Nakamura A, Shimizu C, Nagai S et al (2006) A novel mutation of WFS1 gene in a Japanese man of Wolfram syndrome with positive diabetes-related antibodies. Diabetes Res Clin Pract 73:215\u2013217. https:\/\/doi.org\/10.1016\/J.DIABRES.2005.12.007","journal-title":"Diabetes Res Clin Pract"},{"key":"2495_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/IJERPH19052755","author":"D Iafusco","year":"2022","unstructured":"Iafusco D, Zanfardino A, Piscopo A et al (2022) Metabolic treatment of Wolfram Syndrome. Int J Environ Res Public Health 19. https:\/\/doi.org\/10.3390\/IJERPH19052755","journal-title":"Int J Environ Res Public Health"},{"key":"2495_CR18","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.2337\/DC07-0380","volume":"30","author":"A Cano","year":"2007","unstructured":"Cano A, Molines L, Val\u00e9ro R et al (2007) Microvascular diabetes complications in Wolfram syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness [DIDMOAD]): an age- and duration-matched comparison with common type 1 diabetes. Diabetes Care 30:2327\u20132330. https:\/\/doi.org\/10.2337\/DC07-0380","journal-title":"Diabetes Care"},{"key":"2495_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/J.AJO.2022.03.019","volume":"241","author":"P Barboni","year":"2022","unstructured":"Barboni P, Amore G, Cascavilla ML et al (2022) The pattern of retinal ganglion cell loss in Wolfram Syndrome is distinct from mitochondrial Optic neuropathies. Am J Ophthalmol 241:206\u2013216. https:\/\/doi.org\/10.1016\/J.AJO.2022.03.019","journal-title":"Am J Ophthalmol"},{"key":"2495_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/J.JNS.2022.120267","author":"A Kabanovski","year":"2022","unstructured":"Kabanovski A, Donaldson L, Margolin E (2022) Neuro-ophthalmological manifestations of Wolfram syndrome: Case series and review of the literature. J Neurol Sci 437. https:\/\/doi.org\/10.1016\/J.JNS.2022.120267","journal-title":"J Neurol Sci"},{"key":"2495_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/J.AJO.2022.04.003","volume":"241","author":"A Majander","year":"2022","unstructured":"Majander A, Jurkute N, Burt\u00e9 F et al (2022) WFS1-Associated Optic Neuropathy: genotype-phenotype correlations and Disease Progression. Am J Ophthalmol 241:9\u201327. https:\/\/doi.org\/10.1016\/J.AJO.2022.04.003","journal-title":"Am J Ophthalmol"},{"key":"2495_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000001981","author":"B Tombolini","year":"2023","unstructured":"Tombolini B, Battista M, Borrelli E et al (2023) Wolfram Syndrome: only a neurodegenerative disease or also a Maculopathy? J Neuroophthalmol. https:\/\/doi.org\/10.1097\/WNO.0000000000001981","journal-title":"J Neuroophthalmol"},{"key":"2495_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/HEALTHCARE11131888","author":"G Esteban-Bueno","year":"2023","unstructured":"Esteban-Bueno G, Berenguel Hern\u00e1ndez AM, Fern\u00e1ndez Fern\u00e1ndez N et al (2023) Neurosensory affectation in patients affected by Wolfram Syndrome: descriptive and longitudinal analysis. Healthc (Basel) 11. https:\/\/doi.org\/10.3390\/HEALTHCARE11131888","journal-title":"Healthc (Basel)"},{"key":"2495_CR24","doi-asserted-by":"publisher","first-page":"1155644","DOI":"10.3389\/FENDO.2023.1155644\/BIBTEX","volume":"14","author":"G Frontino","year":"2023","unstructured":"Frontino G, Di Tonno R, Stancampiano MR et al (2023) Paediatric Wolfram syndrome type 1: should gonadal dysfunction be part of the diagnostic criteria? Front Endocrinol (Lausanne) 14:1155644. https:\/\/doi.org\/10.3389\/FENDO.2023.1155644\/BIBTEX","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2495_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/IJERPH182211994","author":"A La Valle","year":"2021","unstructured":"La Valle A, Piccolo G, Maghnie M, D\u2019Annunzio G (2021) Urinary tract involvement in Wolfram Syndrome: a narrative review. Int J Environ Res Public Health 18. https:\/\/doi.org\/10.3390\/IJERPH182211994","journal-title":"Int J Environ Res Public Health"},{"key":"2495_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/J.GAITPOST.2012.06.008","volume":"36","author":"KA Pickett","year":"2012","unstructured":"Pickett KA, Duncan RP, Paciorkowski AR et al (2012) Balance impairment in individuals with Wolfram syndrome. Gait Posture 36:619\u2013624. https:\/\/doi.org\/10.1016\/J.GAITPOST.2012.06.008","journal-title":"Gait Posture"},{"key":"2495_CR27","doi-asserted-by":"publisher","first-page":"40604","DOI":"10.1371\/JOURNAL.PONE.0040604","volume":"7","author":"T Hershey","year":"2012","unstructured":"Hershey T, Lugar HM, Shimony JS et al (2012) Early Brain vulnerability in Wolfram Syndrome. PLoS ONE 7:40604. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0040604","journal-title":"PLoS ONE"},{"key":"2495_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/PEDI.13291","volume":"23","author":"MK Ray","year":"2022","unstructured":"Ray MK, Chen L, White NH et al (2022) Longitudinal progression of diabetes mellitus in Wolfram syndrome: the Washington University Wolfram Research Clinic experience. Pediatr Diabetes 23:212\u2013218. https:\/\/doi.org\/10.1111\/PEDI.13291","journal-title":"Pediatr Diabetes"},{"key":"2495_CR29","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0571","author":"LL Bonnycastle","year":"2013","unstructured":"Bonnycastle LL, Chines PS, Hara T et al (2013) Autosomal dominant diabetes arising from a Wolfram syndrome 1 mutation. Diabetes 62. https:\/\/doi.org\/10.2337\/db13-0571","journal-title":"Diabetes"},{"key":"2495_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2013.52","author":"V Berry","year":"2013","unstructured":"Berry V, Gregory-Evans C, Emmett W et al (2013) Wolfram gene (WFS1) mutation causes autosomal dominant congenital nuclear cataract in humans. Eur J Hum Genet 21. https:\/\/doi.org\/10.1038\/ejhg.2013.52","journal-title":"Eur J Hum Genet"},{"key":"2495_CR31","unstructured":"Hogewind BFT, Pennings RJE, Hol FA et al (2010) Autosomal dominant optic neuropathy and sensorineual hearing loss associated with a novel mutation of WFS1. Mol Vis 16"},{"key":"2495_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2005.034892","author":"H Eiberg","year":"2006","unstructured":"Eiberg H, Hansen L, Kjer B et al (2006) Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene. J Med Genet 43. https:\/\/doi.org\/10.1136\/jmg.2005.034892","journal-title":"J Med Genet"},{"key":"2495_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2011.08.005","author":"SA Yuca","year":"2012","unstructured":"Yuca SA, Rendtorff ND, Boulahbel H et al (2012) Rapidly progressive renal disease as part of Wolfram syndrome in a large inbred Turkish family due to a novel WFS1 mutation (p.Leu511Pro). Eur J Med Genet. https:\/\/doi.org\/10.1016\/j.ejmg.2011.08.005","journal-title":"Eur J Med Genet"},{"key":"2495_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/J.SURVOPHTHAL.2023.01.012","volume":"68","author":"C de Muijnck","year":"2023","unstructured":"de Muijnck C, ten Brink JB, Bergen AA et al (2023) Delineating Wolfram-Like syndrome: a systematic review and discussion of the WFS1-associated disease spectrum. Surv Ophthalmol 68:641\u2013654. https:\/\/doi.org\/10.1016\/J.SURVOPHTHAL.2023.01.012","journal-title":"Surv Ophthalmol"},{"key":"2495_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/JMEDGENET-2018-105782","volume":"57","author":"L Lusk","year":"2020","unstructured":"Lusk L, Black E, Vengoechea J (2020) Segregation of two variants suggests the presence of autosomal dominant and recessive forms of WFS1-related disease within the same family: expanding the phenotypic spectrum of Wolfram Syndrome. J Med Genet 57:121\u2013123. https:\/\/doi.org\/10.1136\/JMEDGENET-2018-105782","journal-title":"J Med Genet"},{"key":"2495_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.14712\/18059694.2019.96","volume":"44","author":"A Kadayifci","year":"2019","unstructured":"Kadayifci A, Kepekci Y, Coskun Y, Huang Y (2019) Wolfram Syndrome in a family with variable expression. Acta Med (Hradec Kralove Czech Republic) 44:115\u2013118. https:\/\/doi.org\/10.14712\/18059694.2019.96","journal-title":"Acta Med (Hradec Kralove Czech Republic)"},{"key":"2495_CR37","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/AJMG.A.33970","volume":"155A","author":"ND Rendtorff","year":"2011","unstructured":"Rendtorff ND, Lodahl M, Boulahbel H et al (2011) Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment. Am J Med Genet A 155A:1298\u20131313. https:\/\/doi.org\/10.1002\/AJMG.A.33970","journal-title":"Am J Med Genet A"},{"key":"2495_CR38","doi-asserted-by":"publisher","first-page":"e0193359","DOI":"10.1371\/JOURNAL.PONE.0193359","volume":"13","author":"M Kobayashi","year":"2018","unstructured":"Kobayashi M, Miyagawa M, Nishio S, ya et al (2018) WFS1 mutation screening in a large series of Japanese hearing loss patients: massively parallel DNA sequencing-based analysis. PLoS ONE 13:e0193359. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0193359","journal-title":"PLoS ONE"},{"key":"2495_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.09.007","author":"D Takei","year":"2006","unstructured":"Takei D, Ishihara H, Yamaguchi S et al (2006) WFS1 protein modulates the free Ca2\u2009+\u2009concentration in the endoplasmic reticulum. FEBS Lett. https:\/\/doi.org\/10.1016\/j.febslet.2006.09.007. 580:","journal-title":"FEBS Lett"},{"key":"2495_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Sci 17. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Sci"},{"key":"2495_CR41","doi-asserted-by":"publisher","DOI":"10.1086\/520961","author":"S Amr","year":"2007","unstructured":"Amr S, Heisey C, Zhang M et al (2007) A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2. Am J Hum Genet. https:\/\/doi.org\/10.1086\/520961","journal-title":"Am J Hum Genet"},{"key":"2495_CR42","doi-asserted-by":"publisher","unstructured":"De Heredia ML, Cl\u00e8ries R, Nunes V (2013) Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype. Genet Sci 15(7):497\u2013506. https:\/\/doi.org\/10.1038\/gim.2012.180","DOI":"10.1038\/gim.2012.180"},{"key":"2495_CR43","volume-title":"Wolfram Syndrome: Diagnosis, Management, and Treatment","author":"F Urano","year":"2016","unstructured":"Urano F (2016) Wolfram Syndrome: diagnosis, management, and treatment. Curr Diab Rep"},{"key":"2495_CR44","doi-asserted-by":"publisher","unstructured":"Khanim F, Kirk J, Latif F, Barrett TG (2001) WFS1\/wolframin mutations, Wolfram syndrome, and associated diseases. Hum Mutat 17(5):357\u2013367. https:\/\/doi.org\/10.1002\/humu.1110","DOI":"10.1002\/humu.1110"},{"key":"2495_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1198171","author":"EM Lee","year":"2023","unstructured":"Lee EM, Verma M, Palaniappan N et al (2023) Genotype and clinical characteristics of patients with Wolfram syndrome and WFS1-related disorders. Front Genet 14. https:\/\/doi.org\/10.3389\/fgene.2023.1198171","journal-title":"Front Genet"},{"key":"2495_CR46","unstructured":"Transcript, #00023835 (2024) Apr (NM_006005.3, WFS1 gene) - Global Variome shared LOVD. https:\/\/databases.lovd.nl\/shared\/transcripts\/00023835. Accessed 22"},{"key":"2495_CR47","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/IJERPH19020835","volume":"19","author":"FM Rosanio","year":"2022","unstructured":"Rosanio FM, Di Candia F, Occhiati L et al (2022) Wolfram Syndrome Type 2: a systematic review of a not easily identifiable clinical spectrum. Int J Environ Res Public Health 2022 19:835. https:\/\/doi.org\/10.3390\/IJERPH19020835","journal-title":"Int J Environ Res Public Health 2022"},{"key":"2495_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/jmg-2023-109488","volume":"61","author":"N Walsh","year":"2024","unstructured":"Walsh N, Cooper A, Dockery A, O\u2019byrne JJ (2024) Variant reclassification and clinical implications. J Med Genet 61:207\u2013211. https:\/\/doi.org\/10.1136\/jmg-2023-109488","journal-title":"J Med Genet"},{"key":"2495_CR49","volume-title":"The central role of calcium in the effects of cytokines on beta-cell function: Implications for type 1 and type 2 diabetes","author":"JW Ramadan","year":"2011","unstructured":"Ramadan JW, Steiner SR, O\u2019Neill CM, Nunemaker CS (2011) The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes. Cell Calcium"},{"key":"2495_CR50","volume-title":"Wolfram syndrome, a rare neurodegenerative disease: From pathogenesis to future treatment perspectives","author":"MT Pallotta","year":"2019","unstructured":"Pallotta MT, Tascini G, Crispoldi R et al (2019) Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives. J Transl Med"},{"key":"2495_CR51","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0717","author":"L Shang","year":"2014","unstructured":"Shang L, Hua H, Foo K et al (2014) \u03b2-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome. Diabetes. https:\/\/doi.org\/10.2337\/db13-0717","journal-title":"Diabetes"},{"key":"2495_CR52","doi-asserted-by":"publisher","unstructured":"Krause T, Gerbershagen MU, Fiege M et al (2004) Dantrolene - A review of its pharmacology, therapeutic use and new developments. Anaesthesia 59(4):364\u2013373. https:\/\/doi.org\/10.1111\/j.1365-2044.2004.03658.x","DOI":"10.1111\/j.1365-2044.2004.03658.x"},{"key":"2495_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu499","author":"M Zatyka","year":"2015","unstructured":"Zatyka M, Da Silva Xavier G, Bellomo EA et al (2015) Sarco(endo)plasmic reticulum atpase is a molecular partner of Wolfram syndrome 1 protein, which negatively regulates its expression. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddu499","journal-title":"Hum Mol Genet"},{"key":"2495_CR54","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddab040","author":"E Panfili","year":"2021","unstructured":"Panfili E, Mondanelli G, Orabona C et al (2021) Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddab040","journal-title":"Hum Mol Genet"},{"key":"2495_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.755365","author":"G Frontino","year":"2021","unstructured":"Frontino G, Raouf G, Canarutto T et al (2021) Case report: off-label liraglutide use in children with wolfram syndrome type 1: extensive characterization of four patients. Front Pediatr 14:9:755365. https:\/\/doi.org\/10.3389\/fped.2021.755365","journal-title":"Frontiers in Pediatrics"},{"key":"2495_CR56","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/BIOM14070872\/S1","volume":"14","author":"KO Kopp","year":"2024","unstructured":"Kopp KO, Li Y, Glotfelty EJ et al (2024) Incretin-based multi-agonist peptides are neuroprotective and anti-inflammatory in Cellular models of Neurodegeneration. Biomolecules 14:872. https:\/\/doi.org\/10.3390\/BIOM14070872\/S1","journal-title":"Biomolecules"},{"key":"2495_CR57","doi-asserted-by":"publisher","unstructured":"Samara A, Rahn R, Neyman O et al (2019) Developmental hypomyelination in Wolfram syndrome: new insights from neuroimaging and gene expression analyses. Orphanet J Rare Dis 14(1):279. https:\/\/doi.org\/10.1186\/s13023-019-1260-9","DOI":"10.1186\/s13023-019-1260-9"},{"key":"2495_CR58","doi-asserted-by":"publisher","DOI":"10.3233\/trd-170012","author":"T Doty","year":"2017","unstructured":"Doty T, Foster ER, Marshall B et al (2017) The effects of disease-related symptoms on daily function in Wolfram Syndrome. Transl Sci Rare Dis 2. https:\/\/doi.org\/10.3233\/trd-170012","journal-title":"Transl Sci Rare Dis"},{"key":"2495_CR59","volume-title":"WFS1 Spectrum Disorder","author":"T Barrett","year":"2022","unstructured":"Barrett T, Tranebj\u00e6rg L, Gupta R et al (2022) WFS1 spectrum disorder. In: Gene Reviews"},{"key":"2495_CR60","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/ARCHDISCHILD-2017-313208","volume":"103","author":"ER Willis","year":"2018","unstructured":"Willis ER, McDonagh JE (2018) Transition from children\u2019s to adults\u2019 services for young people using health or social care services (NICE Guideline NG43). Arch Dis Child Educ Pract Ed 103:253\u2013256. https:\/\/doi.org\/10.1136\/ARCHDISCHILD-2017-313208","journal-title":"Arch Dis Child Educ Pract Ed"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02495-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T05:28:04Z","timestamp":1740979684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02495-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["2495"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02495-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors have no financial interests to disclosure. Lorenzo Piemonti is Associate editor of the Journal of Endocrinological Investigation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}